The Emerging Roles of Exosomal miRNAs in Breast Cancer Progression and Potential Clinical Applications

References

• Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet. 2021;397(10286):1750–1769. doi:10.1016/S0140-6736(20)32381-3
   PubMed Web of Science ®Google Scholar
• Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J. 2021;134(7):783–791. doi:10.1097/CM9.0000000000001474
   PubMed Web of Science ®Google Scholar
• Arnold M, Morgan E, Rumgay H, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. The Breast. 2022;66:15–23. doi:10.1016/j.breast.2022.08.010
   PubMed Web of Science ®Google Scholar
• von Arx C, De Placido P, Caltavituro A, et al. The evolving therapeutic landscape of trastuzumab-drug conjugates: future perspectives beyond HER2-positive breast cancer. Cancer Treat Rev. 2023;113:102500. doi:10.1016/j.ctrv.2022.102500
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Paskeh MDA, Entezari M, Mirzaei S, et al. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. J Hematol Oncol. 2022;15(1):83. doi:10.1186/s13045-022-01305-4
   PubMed Web of Science ®Google Scholar
• Yang E, Wang X, Gong Z, Yu M, Wu H, Zhang D. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Signal Transduct Target Ther. 2020;5(1):242. doi:10.1038/s41392-020-00359-5
   PubMed Web of Science ®Google Scholar
• Fang Z, Ding Y, Xue Z, Li P, Li J, Li F. Roles of exosomes as drug delivery systems in cancer immunotherapy: a mini-review. Discov Oncol. 2022;13(1):74. doi:10.1007/s12672-022-00539-5
   PubMedGoogle Scholar
• Xu YX, Pu SD, Li X, et al. Exosomal ncRNAs: novel therapeutic target and biomarker for diabetic complications. Pharmacol Res. 2022;178:106135. doi:10.1016/j.phrs.2022.106135
   PubMed Web of Science ®Google Scholar
• Sammut SJ, Crispin-Ortuzar M, Chin SF, et al. Multi-omic machine learning predictor of breast cancer therapy response. Nature. 2022;601(7894):623–629.
   PubMed Web of Science ®Google Scholar
• DeVeale B, Swindlehurst-Chan J, Blelloch R. The roles of microRNAs in mouse development. Nat Rev Genet. 2021;22(5):307–323. doi:10.1038/s41576-020-00309-5
   PubMed Web of Science ®Google Scholar
• Mori MA, Ludwig RG, Garcia-Martin R, Brandão BB, Kahn CR. Extracellular miRNAs: from biomarkers to mediators of physiology and disease. Cell Metab. 2019;30(4):656–673. doi:10.1016/j.cmet.2019.07.011
   PubMed Web of Science ®Google Scholar
• Melo SA, Sugimoto H, O’Connell JT, et al. Cancer exosomes perform cell-independent microrna biogenesis and promote tumorigenesis. Cancer Cell. 2014;26(5):707–721. doi:10.1016/j.ccell.2014.09.005
   PubMed Web of Science ®Google Scholar
• Scognamiglio I, Cocca L, Puoti I, et al. Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer. Mol Ther Nucleic Acid. 2022;28:17–31. doi:10.1016/j.omtn.2022.02.013
   PubMedGoogle Scholar
• Zhao S, Pan T, Deng J, et al. Exosomal transfer of miR-181b-5p confers senescence-mediated doxorubicin resistance via modulating BCLAF1 in breast cancer. Br J Cancer. 2023;128(4):665–677. doi:10.1038/s41416-022-02077-x
   PubMed Web of Science ®Google Scholar
• Sun S, Wang Z, Yao F, et al. Breast cancer cell-derived exosome-delivered microRNA-155 targets UBQLN1 in adipocytes and facilitates cancer cachexia-related fat loss. Hum Mol Genet. 2023;32(13):2219–2228. doi:10.1093/hmg/ddad055
   PubMed Web of Science ®Google Scholar
• Kim O, Tran P, Gal M, et al. RAS‑stimulated release of exosomal miR‑494‑3p promotes the osteolytic bone metastasis of breast cancer cells. Int J Mol Med. 2023;52(3):84. doi:10.3892/ijmm.2023.5287
   PubMed Web of Science ®Google Scholar
• Liu C, Li B, Lin H, et al. Multiplexed analysis of small extracellular vesicle-derived mRNAs by droplet digital PCR and machine learning improves breast cancer diagnosis. Biosens Bioelectron. 2021;194:113615. doi:10.1016/j.bios.2021.113615
   PubMed Web of Science ®Google Scholar
• Li X, Wang S, Mu W, et al. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway. J Exp Clin Cancer Res. 2022;41(1):41. doi:10.1186/s13046-022-02244-1
   PubMed Web of Science ®Google Scholar
• Santos JC, Sarian LO, Matheu A, Ribeiro ML, Derchain SFM, Derchain SFM. Exosome-mediated breast cancer chemoresistance via miR-155 transfer. Sci Rep. 2018;8(1):829. doi:10.1038/s41598-018-19339-5
   PubMed Web of Science ®Google Scholar
• Kia V, Paryan M, Mortazavi Y, Biglari A, Mohammadi-Yeganeh S. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells. J Cell Biochem. 2019;120(4):5666–5676. doi:10.1002/jcb.27850
   PubMed Web of Science ®Google Scholar
• Huang X, Lai S, Qu F, et al. CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6/Src/PI3K/Akt pathway. Mol Ther Oncol. 2022;25(26):1–15. doi:10.1016/j.omto.2022.03.004
   PubMedGoogle Scholar
• Yang C, Zhang G, Zhang Y, Zhang S, Li J, Liu Y. Exosome miR-134-5p restrains breast cancer progression via regulating PI3K/AKT pathway by targeting ARHGAP1. J Obstet Gynaecol Res. 2021;47(11):4037–4048. doi:10.1111/jog.14983
   PubMed Web of Science ®Google Scholar
• Singh R, Pochampally R, Watabe K, Lu Z, Mo YY. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol Cancer. 2014;13(1):256. doi:10.1186/1476-4598-13-256
   PubMedGoogle Scholar
• Ding J, Xu Z, Zhang Y, et al. Exosome-mediated miR-222 transferring: an insight into NF-κB-mediated breast cancer metastasis. Exp Cell Res. 2018;369(1):129–138. doi:10.1016/j.yexcr.2018.05.014
   PubMed Web of Science ®Google Scholar
• Wang B, Mao J, Wang B, et al. Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-κB signaling pathway. Cancer Lett. 2020;489:87–99. doi:10.1016/j.canlet.2020.05.038
   PubMed Web of Science ®Google Scholar
• Wang X, Qian T, Bao S, et al. Circulating exosomal miR-363-5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer. Mol Oncol. 2021;15(9):2466–2479. doi:10.1002/1878-0261.13029
   PubMed Web of Science ®Google Scholar
• Shen S, Song Y, Zhao B, et al. Cancer-derived exosomal miR-7641 promotes breast cancer progression and metastasis. Cell Commun Signal. 2021;19(1):20. doi:10.1186/s12964-020-00700-z
   PubMed Web of Science ®Google Scholar
• Liang Z, Liu L, Gao R, Che C, Yang G. Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway. Cell Mol Biol Lett. 2022;27(1):88. doi:10.1186/s11658-022-00393-x
   PubMed Web of Science ®Google Scholar
• AL-Abedi R, Tuncay Cagatay S, Mayah A, Brooks SA, Kadhim M. Ionising radiation promotes invasive potential of breast cancer cells: the role of exosomes in the process. Int J Mol Sci. 2021;22(21):11570. doi:10.3390/ijms222111570
   PubMed Web of Science ®Google Scholar
• Yang SS, Ma S, Dou H, et al. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment. Exp Cell Res. 2020;391(2):111983. doi:10.1016/j.yexcr.2020.111983
   PubMed Web of Science ®Google Scholar
• Baroni S, Romero-Cordoba S, Plantamura I, et al. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts. Cell Death Dis. 2016;7(7):e2312–e2312. doi:10.1038/cddis.2016.224
   PubMedGoogle Scholar
• Pakravan K, Mossahebi-Mohammadi M, Ghazimoradi MH, Cho WC, Sadeghizadeh M, Babashah S. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells. J Transl Med. 2022;20(1):559. doi:10.1186/s12967-022-03780-2
   PubMed Web of Science ®Google Scholar
• Wu Q, Li J, Li Z, et al. Exosomes from the tumour-adipocyte interplay stimulate beige/brown differentiation and reprogram metabolism in stromal adipocytes to promote tumour progression. J Exp Clin Cancer Res. 2019;38(1):223. doi:10.1186/s13046-019-1210-3
   PubMedGoogle Scholar
• Hashimoto K, Ochi H, Sunamura S, et al. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A. Proc Natl Acad Sci. 2018;115(9):2204–2209. doi:10.1073/pnas.1717363115
   PubMed Web of Science ®Google Scholar
• Feng Y, Wang L, Wang T, et al. Tumor cell-secreted exosomal miR-22-3p inhibits transgelin and induces vascular abnormalization to promote tumor budding. Mol Ther. 2021;29(6):2151–2166. doi:10.1016/j.ymthe.2021.02.009
   PubMed Web of Science ®Google Scholar
• Zhou W, Fong MY, Min Y, et al. Cancer-Secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014;25(4):501–515. doi:10.1016/j.ccr.2014.03.007
   PubMed Web of Science ®Google Scholar
• Di Modica M, Regondi V, Sandri M, et al. Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers. Cancer Lett. 2017;384:94–100. doi:10.1016/j.canlet.2016.09.013
   PubMed Web of Science ®Google Scholar
• Du J, Fan JJ, Dong C, Li HT, Ma BL. Inhibition effect of exosomes-mediated Let-7a on the development and metastasis of Triple negative breast cancer by down-regulating the expression of c-Myc. Eur Rev Med Pharmacol Sci. 2019;23(12):5301–5314. doi:10.26355/eurrev_201906_18197
   PubMed Web of Science ®Google Scholar
• Qi M, Xia Y, Wu Y, et al. Lin28B-high breast cancer cells promote immune suppression in the lung pre-metastatic niche via exosomes and support cancer progression. Nat Commun. 2022;13(1):897. doi:10.1038/s41467-022-28438-x
   PubMed Web of Science ®Google Scholar
• Fong MY, Zhou W, Liu L, et al. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol. 2015;17(2):183–194. doi:10.1038/ncb3094
   PubMed Web of Science ®Google Scholar
• Yan W, Wu X, Zhou W, et al. Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat Cell Biol. 2018;20(5):597–609. doi:10.1038/s41556-018-0083-6
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang Q, Wang D, et al. Microenvironment-induced TIMP2 loss by cancer-secreted exosomal miR-4443 promotes liver metastasis of breast cancer. J Cell Physiol. 2020;235(7––8):5722–5735. doi:10.1002/jcp.29507
   PubMed Web of Science ®Google Scholar
• Wu K, Feng J, Lyu F, et al. Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer. Nat Commun. 2021;12(1):5196. doi:10.1038/s41467-021-25473-y
   PubMed Web of Science ®Google Scholar
• Guo L, Zhu Y, Li L, et al. Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1. Cancer Med. 2019;8(12):5687–5701. doi:10.1002/cam4.2454
   PubMed Web of Science ®Google Scholar
• Yuan X, Qian N, Ling S, et al. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells. Theranostics. 2021;11(3):1429–1445. doi:10.7150/thno.45351
   PubMed Web of Science ®Google Scholar
• Wu HJ, Hao M, Yeo SK, Guan JL. FAK signaling in cancer-associated fibroblasts promotes breast cancer cell migration and metastasis by exosomal miRNAs-mediated intercellular communication. Oncogene. 2020;39(12):2539–2549. doi:10.1038/s41388-020-1162-2
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang Y, Du J, Lin D, Li F. MiR-3613-3p from carcinoma-associated fibroblasts exosomes promoted breast cancer cell proliferation and metastasis by regulating SOCS2 expression. IUBMB Life. 2020;72(8):1705–1714. doi:10.1002/iub.2292
   PubMed Web of Science ®Google Scholar
• Yan Z, Sheng Z, Zheng Y, et al. Cancer-associated fibroblast-derived exosomal miR-18b promotes breast cancer invasion and metastasis by regulating TCEAL7. Cell Death Dis. 2021;12(12):1120. doi:10.1038/s41419-021-04409-w
   PubMed Web of Science ®Google Scholar
• Chen B, Sang Y, Song X, et al. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Theranostics. 2021;11(8):3932–3947. doi:10.7150/thno.53412
   PubMed Web of Science ®Google Scholar
• Kim JE, Kim BG, Jang Y, Kang S, Lee JH, Cho NH. The stromal loss of miR-4516 promotes the FOSL1-dependent proliferation and malignancy of triple negative breast cancer. Cancer Lett. 2020;469:256–265. doi:10.1016/j.canlet.2019.10.039
   PubMed Web of Science ®Google Scholar
• Pakravan K, Babashah S, Sadeghizadeh M, et al. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells. Cell Oncol. 2017;40(5):457–470. doi:10.1007/s13402-017-0335-7
   PubMed Web of Science ®Google Scholar
• Lee JK, Park SR, Jung BK, et al. Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One. 2013;8(12):e84256. doi:10.1371/journal.pone.0084256
   PubMed Web of Science ®Google Scholar
• Xing L, Tang X, Wu K, Huang X, Yi Y, Huan J. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p. Aging. 2021;13(1):424–436. doi:10.18632/aging.202148
   Google Scholar
• Ono M, Kosaka N, Tominaga N, et al. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal. 2014;7(332):ra63. doi:10.1126/scisignal.2005231
   PubMed Web of Science ®Google Scholar
• Bliss SA, Sinha G, Sandiford OA, et al. Mesenchymal stem cell-derived exosomes stimulate cycling quiescence and early breast cancer dormancy in bone marrow. Cancer Res. 2016;76(19):5832–5844. doi:10.1158/0008-5472.CAN-16-1092
   PubMed Web of Science ®Google Scholar
• Gernapudi R, Yao Y, Zhang Y, et al. Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer. Breast Cancer Res Treat. 2015;150(3):685–695. doi:10.1007/s10549-015-3326-2
   PubMed Web of Science ®Google Scholar
• Chow A, Schad S, Green MD, et al. Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity. Cancer Cell. 2021;39(7):973–988.e9. doi:10.1016/j.ccell.2021.05.006
   PubMed Web of Science ®Google Scholar
• Moradi-Chaleshtori M, Bandehpour M, Heidari N, Mohammadi-Yeganeh S, Mahmoud Hashemi S. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line. Int Immunopharmacol. 2021;90:107198. doi:10.1016/j.intimp.2020.107198
   PubMed Web of Science ®Google Scholar
• Moradi-Chaleshtori M, Shojaei S, Mohammadi-Yeganeh S, Hashemi SM. Transfer of miRNA in tumor-derived exosomes suppresses breast tumor cell invasion and migration by inducing M1 polarization in macrophages. Life Sci. 2021;282:119800. doi:10.1016/j.lfs.2021.119800
   PubMed Web of Science ®Google Scholar
• Moradi-Chaleshtori M, Bandehpour M, Soudi S, Mohammadi-Yeganeh S, Hashemi SM. In vitro and in vivo evaluation of anti-tumoral effect of M1 phenotype induction in macrophages by miR-130 and miR-33 containing exosomes. Cancer Immunol Immunother. 2021;70(5):1323–1339. doi:10.1007/s00262-020-02762-x
   PubMed Web of Science ®Google Scholar
• Guo J, Duan Z, Zhang C, et al. Mouse 4T1 breast cancer cell–derived exosomes induce proinflammatory cytokine production in macrophages via miR-183. J Immunol. 2020;205(10):2916–2925. doi:10.4049/jimmunol.1901104
   PubMed Web of Science ®Google Scholar
• Chen WX, Wang DD, Zhu B, et al. Exosomal miR-222 from Adriamycin-resistant MCF-7 breast cancer cells promote macrophages M2 polarization via PTEN/Akt to induce tumor progression. Aging. 2021;13(7):10415–10430. doi:10.18632/aging.202802
   PubMedGoogle Scholar
• Hao C, Sheng Z, Wang W, et al. Tumor-derived exosomal miR-148b-3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion. Thorac Cancer. 2023;14(16):1477–1491. doi:10.1111/1759-7714.14891
   PubMed Web of Science ®Google Scholar
• Xun J, Du L, Gao R, et al. Cancer-derived exosomal miR-138-5p modulates polarization of tumor-Associated macrophages through inhibition of KDM6B. Theranostics. 2021;11(14):6847–6859. doi:10.7150/thno.51864
   PubMed Web of Science ®Google Scholar
• Xing F, Liu Y, Wu SY, et al. Loss of XIST in breast cancer activates MSN-c-Met and reprograms microglia via exosomal miRNA to promote brain metastasis. Cancer Res. 2018;78(15):4316–4330. doi:10.1158/0008-5472.CAN-18-1102
   PubMed Web of Science ®Google Scholar
• Yang M, Chen J, Su F, et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer. 2011;10(1):117. doi:10.1186/1476-4598-10-117
   PubMed Web of Science ®Google Scholar
• Yue S, Ye X, Zhou T, et al. PGRN TAMs-derived exosomes inhibit breast cancer cell invasion and migration and its mechanism exploration. Life Sci. 2021;264:118687. doi:10.1016/j.lfs.2020.118687
   PubMed Web of Science ®Google Scholar
• Huang S, Fan P, Zhang C, et al. Exosomal microRNA-503-3p derived from macrophages represses glycolysis and promotes mitochondrial oxidative phosphorylation in breast cancer cells by elevating DACT2. Cell Death Discov. 2021;7(1):119. doi:10.1038/s41420-021-00492-2
   PubMed Web of Science ®Google Scholar
• Grover A, Sanseviero E, Timosenko E, Gabrilovich DI. Myeloid-derived suppressor cells: a propitious road to clinic. Cancer Discov. 2021;11(11):2693–2706. doi:10.1158/2159-8290.CD-21-0764
   PubMed Web of Science ®Google Scholar
• Jiang M, Zhang W, Zhang R, et al. Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer. Oncogene. 2020;39(24):4681–4694. doi:10.1038/s41388-020-1322-4
   PubMed Web of Science ®Google Scholar
• Deng Z, Rong Y, Teng Y, et al. Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis. Oncogene. 2017;36(5):639–651. doi:10.1038/onc.2016.229
   PubMed Web of Science ®Google Scholar
• Lv S, Wang Y, Xu W, Dong X. Serum exosomal miR-17-5p as a promising biomarker diagnostic biomarker for breast cancer. Clin Lab. 2020;66(9):1823–1834. doi:10.7754/Clin.Lab.2020.200127
   Web of Science ®Google Scholar
• Liu D, Li B, Shi X, et al. Cross-platform genomic identification and clinical validation of breast cancer diagnostic biomarkers. Aging. 2021;13(3):4258–4273. doi:10.18632/aging.202388
   PubMedGoogle Scholar
• Kim J, Park S, Hwang D, Kim S, Lee H. Diagnostic value of circulating miR-202 in early-stage breast cancer in South Korea. Medicina. 2020;56(7):340. doi:10.3390/medicina56070340
   PubMedGoogle Scholar
• Xin Y, Wang X, Meng K, Ni C, Lv Z, Guan D. Identification of exosomal miR-455-5p and miR-1255a as therapeutic targets for breast cancer. Biosci Rep. 2020;40(1):BSR20190303. doi:10.1042/BSR20190303
   PubMedGoogle Scholar
• Zhang Z, Zhang L, Yu G, et al. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer. Cancer Chemother Pharmacol. 2020;86(6):761–772. doi:10.1007/s00280-020-04168-z
   PubMed Web of Science ®Google Scholar
• Li XJ, Ren ZJ, Tang JH, Yu Q. Exosomal MicroRNA MiR-1246 promotes cell proliferation, invasion and drug resistance by targeting CCNG2 in breast cancer. Cell Physiol Biochem. 2018;44(5):1741–1748. doi:10.1159/000485780
   Google Scholar
• Yoshikawa M, Iinuma H, Umemoto Y, Yanagisawa T, Matsumoto A, Jinno H. Exosome-encapsulated microRNA-223-3p as a minimally invasive biomarker for the early detection of invasive breast cancer. Oncol Lett. 2018;15(6):9584–9592. doi:10.3892/ol.2018.8457
   PubMed Web of Science ®Google Scholar
• Asadirad A, Khodadadi A, Talaiezadeh A, Shohan M, Rashno M, Joudaki N. Evaluation of miRNA-21-5p and miRNA-10b-5p levels in serum-derived exosomes of breast cancer patients in different grades. Mol Cell Probes. 2022;64:101831. doi:10.1016/j.mcp.2022.101831
   PubMed Web of Science ®Google Scholar
• Curtaz CJ, Reifschläger L, Strähle L, et al. Analysis of microRNAs in exosomes of breast cancer patients in search of molecular prognostic factors in brain metastases. Int J Mol Sci. 2022;23(7):3683. doi:10.3390/ijms23073683
   PubMed Web of Science ®Google Scholar
• Li D, Wang J, Ma LJ, et al. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer. Eur Rev Med Pharmacol Sci. 2020;24(13):7303–7309. doi:10.26355/eurrev_202007_21889
   PubMed Web of Science ®Google Scholar
• Liu M, Mo F, Song X, et al.. Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis. Peer J. 2021;9:e12147.
   PubMed Web of Science ®Google Scholar
• Ando W, Kikuchi K, Uematsu T, et al. Novel breast cancer screening: combined expression of miR-21 and MMP-1 in urinary exosomes detects 95% of breast cancer without metastasis. Sci Rep. 2019;9(1):13595. doi:10.1038/s41598-019-50084-5
   PubMedGoogle Scholar
• Inubushi S, Kawaguchi H, Mizumoto S, et al. Oncogenic miRNAs identified in tear exosomes from metastatic breast cancer patients. Anticancer Res. 2020;40(6):3091–3096. doi:10.21873/anticanres.14290
   PubMed Web of Science ®Google Scholar
• Bao S, Hu T, Liu J, et al. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer. J Nanobiotechnology. 2021;19(1):22. doi:10.1186/s12951-020-00767-3
   PubMed Web of Science ®Google Scholar
• Hannafon BN, Trigoso YD, Calloway CL, et al. Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res. 2016;18(1):90. doi:10.1186/s13058-016-0753-x
   PubMed Web of Science ®Google Scholar
• Li S, Zhang M, Xu F, Wang Y, Leng D. Detection significance of miR-3662, miR-146a, and miR-1290 in serum exosomes of breast cancer patients. J Cancer Res Ther. 2021;17(3):749–755. doi:10.4103/jcrt.jcrt_280_21
   PubMed Web of Science ®Google Scholar
• Rodríguez-Martínez A, de Miguel-Pérez D, Ortega FG, et al. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy. Breast Cancer Res. 2019;21(1):21. doi:10.1186/s13058-019-1109-0
   PubMed Web of Science ®Google Scholar
• Muluhngwi P, Klinge CM. Identification of miRNAs as biomarkers for acquired endocrine resistance in breast cancer. Mol Cell Endocrinol. 2017;456:76–86. doi:10.1016/j.mce.2017.02.004
   PubMed Web of Science ®Google Scholar
• Ryspayeva D, Halytskiy V, Kobyliak N, et al. Response to neoadjuvant chemotherapy in breast cancer: do microRNAs matter? Discov Oncol. 2022;13(1):43. doi:10.1007/s12672-022-00507-z
   PubMedGoogle Scholar
• Guyon N, Garnier D, Briand J, et al. Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells. Cell Death Dis. 2020;11(12):1048. doi:10.1038/s41419-020-03224-z
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhao S, Shi Z, et al. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling. J Exp Clin Cancer Res. 2021;40(1):120. doi:10.1186/s13046-021-01901-1
   PubMed Web of Science ®Google Scholar
• Li Y, Liang Y, Sang Y, et al. MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1. Cell Death Dis. 2018;9(1):14. doi:10.1038/s41419-017-0030-7
   PubMedGoogle Scholar
• Luo L, Zhang X, Rousuli Y, Aini A, Liman R. Exosome-mediated transfer of miR-3613-5Pp enhances doxorubicin resistance by suppression of pten expression in breast cancer cells. J Oncol. 2022;2022:9494910. doi:10.1155/2022/9494910
   PubMed Web of Science ®Google Scholar
• Andreeva OE, Sorokin DV, Mikhaevich EI, et al. Towards unravelling the role of ERα-targeting miRNAs in the exosome-mediated transferring of the hormone resistance. Molecules. 2021;26(21):6661. doi:10.3390/molecules26216661
   PubMed Web of Science ®Google Scholar
• Wei Y, Lai X, Yu S, et al. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Res Treat. 2014;147(2):423–431. doi:10.1007/s10549-014-3037-0
   PubMed Web of Science ®Google Scholar
• Liu J, Zhu S, Tang W, Huang Q, Mei Y, Yang H. Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p. Cancer Cell Int. 2021;21(1):55. doi:10.1186/s12935-020-01659-0
   PubMed Web of Science ®Google Scholar
• Yu S, Zhou Y, Niu L, Qiao Y, Yan Y. Mesenchymal stem cell-derived exosome mir-342-3p inhibits metastasis and chemo-resistance of breast cancer through regulating ID4. Genes Genomics. 2022;44(5):539–550. doi:10.1007/s13258-021-01200-1
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhang J, Liu Y, Peng H, Wu Y. Extracellular vesicles extracted from bone marrow mesenchymal stem cells carrying MicroRNA-342-3p inhibit the INHBA/IL13Rα2 axis to suppress the growth and metastasis of breast cancer. Transl Oncol. 2022;18:101333. doi:10.1016/j.tranon.2021.101333
   PubMed Web of Science ®Google Scholar
• Yang Z, Xu B, Wu S, et al. Exosomal microRNA-551b-3p from bone marrow-derived mesenchymal stromal cells inhibits breast cancer progression via regulating TRIM31/Akt signaling. Hum Cell. 2022;35(6):1797–1812. doi:10.1007/s13577-022-00753-x
   PubMed Web of Science ®Google Scholar
• Jia Z, Zhu H, Sun H, et al. Adipose mesenchymal stem cell-derived exosomal microrna-1236 reduces resistance of breast cancer cells to cisplatin by suppressing slc9a1 and the wnt/β-catenin signaling. Cancer Manag Res. 2020;12:8733–8744. doi:10.2147/CMAR.S270200
   PubMed Web of Science ®Google Scholar
• Du L, Tao X, Shen X. Human umbilical cord mesenchymal stem cell-derived exosomes inhibit migration and invasion of breast cancer cells via miR-21-5p/ZNF367 pathway. Breast Cancer. 2021;28(4):829–837. doi:10.1007/s12282-021-01218-z
   PubMed Web of Science ®Google Scholar
• Khazaei-Poul Y, Shojaei S, Koochaki A, Ghanbarian H, Mohammadi-Yeganeh S. Evaluating the influence of human umbilical cord mesenchymal stem cells-derived exosomes loaded with miR-3182 on metastatic performance of triple negative breast cancer cells. Life Sci. 2021;286:120015. doi:10.1016/j.lfs.2021.120015
   PubMed Web of Science ®Google Scholar
• Yuan L, Liu Y, Qu Y, Liu L, Li H. Exosomes derived from MicroRNA-148b-3p-overexpressing human umbilical cord mesenchymal stem cells restrain breast cancer progression. Front Oncol. 2019;9:1076. doi:10.3389/fonc.2019.01076
   PubMed Web of Science ®Google Scholar
• Sheykhhasan M, Kalhor N, Sheikholeslami A, Dolati M, Amini E, Fazaeli H. Exosomes of mesenchymal stem cells as a proper vehicle for transfecting miR-145 into the breast cancer cell line and its effect on metastasis. Biomed Res Int. 2021;2021:5516078. doi:10.1155/2021/5516078
   PubMed Web of Science ®Google Scholar
• Zhou Y, Chen F, Xie X, et al. Tumor-derived exosome promotes metastasis via altering its phenotype and inclusions. J Cancer. 2021;12(14):4240–4246. doi:10.7150/jca.48043
   PubMed Web of Science ®Google Scholar